Poster 
No. | 
    Presenter | 
    Title | 
  
      
    | P-06 | 
    Hiroshi Arai 
      [Tokyo Medical and Dental Univ.] | 
    Development of small CD4 mimic molecules that induce conformational
changes in gp120 | 
  
   
    
  | 
  
      
    | P-07 | 
    Taro Ozaki 
      [Tokyo Medical and Dental Univ.] | 
    Structure-activity relationships of CXCR4 antagonists having the dipicolylamine/azamacro- cyclic-metal complex structures | 
  
   
    
  | 
  
      
    | P-08 | 
    Taisuke Izumi 
      [Kyoto Univ.] | 
    Model structure of APOBEC3G N-terminal region reveals a biding pocket
modulating HIV-1 Vif interaction and RNA required for encapsidation | 
  
   
    
  | 
  
      
    | P-09 | 
    Terumasa Ikeda 
     [Kumamoto Univ.] | 
    Identification of the functional region required for anti-HIV-1 activity of
APOBEC1 | 
  
   
    
  | 
  
      
    | P-10 | 
    Kazuhiko Maeda 
      [Kumamoto Univ.] | 
    GANP regulates the incorporation of Apobec3G into HIV-1 virions | 
  
   
    
  | 
  
      
    | P-11 | 
    Natsuko Inagaki 
     [Univ. of Tokyo] | 
    Critical amino acid residues for functional interaction between N-terminal
and C-terminal domains in SIV capsid proteins | 
  
   
    
  | 
  
      
    | P-12 | 
    Ken Kono 
      [Osaka Univ.] | 
    Simian-tropic HIV-1 NL-4/5S6/7SvifS shows slower capsid uncoating in
human cells | 
  
   
    
  | 
  
      
    | P-13 | 
    Takeo Kuwata 
      [Kumamoto Univ.] | 
    Isolation of monoclonal neutralizing antibodies from SIV-infected
macaques by phage display | 
  
   
    
  | 
  
      
    | P-14 | 
    Sayaka Sukegawa 
      [Tokyo Medical and Dental Univ.] | 
    Involvement of suppressor of cytokine signaling 1 (SOCS1) protein in the
Rhesus Macaque TRIM5-mediated restriction of HIV-1 production | 
  
   
    
  | 
  
      
    | P-15 | 
    Tomoko Kobayashi 
      [Kyoto Univ.] | 
    Live cell-based mutagenesis studies reveals the structural insights for
human tetherin recognition by HIV-1 Vpu | 
  
   
    
  | 
  
      
    | P-16 | 
    Youichi Ogawa 
      [Univ. of Yamanashi] | 
    Production of LL-37 during herpes simplex virus types 2 infection in
human keratinocytes enhances HIV susceptibility in Langerhans cells, but
not in Dendritic cells | 
  
   
    
  | 
  
      
    | P-17 | 
    Teppei Toda 
      [Kumamoto Univ.] | 
    A novel anti-CD4 monoclonal antibody that inhibits HIV-1 membrane
fusion | 
  
	 
    
  | 
  
  
    | P-18 | 
    Shigeyoshi Harada 
      [Kumamoto Univ.] | 
    Evolution and selection of the env gene of HIV-1 primary isolates during in
vitro selection of raltegravir | 
  
	 
    
  | 
  
   
    | P-19 | 
    Kensaku Anraku 
     [Kumamoto Health Science
Univ.] | 
    Exploration of small molecules that bind HIV-1 MA protein strongly | 
  
	 
    
  | 
  
      
    | P-20 | 
    Masateru Hiyoshi 
      [Kumamoto Univ.] | 
    HIV-1 Nef Perturbs Function, Structure and Signaling of the Golgi through
a Src Kinase Hck | 
  
   
    
  | 
  
      
    | P-21 | 
    Nopporn Chutiwitoonchai 
      [Kumamoto Univ.] | 
    Effect of a small compound and an Hck mutant on HIV-1 infectivity | 
  
   
    
  | 
  
      
    | P-22 | 
    Takashi Chihara 
      [Kumamoto Univ.] | 
    Effect of Nef on anti-inflammatory M2-macrophages | 
  
   
    
  | 
  
      
    | P-23 | 
    Shinichiro Hattori 
      [Kumamoto Univ.] | 
    The kinetic analysis of Foxp3+CD4+ regulatory T cells in HIV-1 infection | 
  
   
    
  | 
  
      
    | P-24 | 
    Ryusho Kariya 
      [Kumamoto Univ.] | 
    HIV protease inhibitor inhibits the growth of primary effusion lymphoma
and induces apoptosis | 
  
   
    
  | 
  
      
    | P-25 | 
    Zafrul Hasan 
      [Kumamoto Univ.] | 
    Implication of the effects of host immune responses on the HIV-1 vpu
gene evolution | 
  
   
    
  | 
  
      
    | P-26 | 
    Philip Mwimanzi 
     [Kumamoto Univ.] | 
    Nef activity in down regulation of viral receptors and protection of HIV
superinfection is modulated by Nef mutations that confer CTL escape
during acute infection | 
  
   
    
  | 
  
      
    | P-27 | 
    Nobutoki Takamune 
      [Kumamoto Univ.] | 
    Potential low protein expression property of Nef | 
  
   
    
  | 
  
      
    | P-28 | 
    Yusuke Nakano 
     [Kumamoto Univ.] | 
    Modification of coreceptor oligomerization by coreceptor inhibitors | 
  
  
   
    
  | 
  
      
    | P-29 | 
    Hiromi Terasawa 
      [Kumamoto Univ.] | 
    Complete Resistance to Maraviroc in R5 HIV-1 with gp120 V3 Loop Mutations Is Affected by T199K and/or T275M in Env | 
  
   
    
  | 
  
      
    | P-30 | 
    Nobuyo Higashi-Kuwata 
      [Kumamoto Univ.] | 
    Early phase dynamics of HIV-1 infection in hPBM-transplanted NOD/SCID/Jak3-/- mice using infectious HIV-1 carrying fluorescent protein mCherry | 
  
   
    
  | 
  
      
    | P-31 | 
    Hiromi Ogata-Aoki 
      [Kumamoto Univ.] | 
    Early Phase Dynamics of HIV Infection in hPBMC-Transplanted NOD/SCID/Jak3-/- Mice Using Infectious HIV Carrying a Fluorescent Protein, mCherry: 2 | 
  
   
    
  | 
  
      
    | P-32 | 
    Yoshinori Sato 
      [Kumamoto Univ.] | 
    Failure of effector function of human CD8+ T cells in NOD/SCID/Jak3-/- mice transplanted with human CD34+ hematopoietic stem cells | 
  
   
    
  | 
  
      
    | P-33 | 
    Masao Hashimoto 
      [Kumamoto Univ.] | 
    HIV-1 specific HLA-B*5401-restricted Pol155-specific CTLs include distinct CTL repertoire with different antigen specificity against epitope variant | 
  
   
    
  | 
  
      
    | P-34 | 
    Nozomi Kuse 
      [Kumamoto Univ.] | 
    Long-term control of HIV-1 infection in HLA-B*5101+ Japanese hemophiliacs | 
  
   
    
  | 
  
      
    | P-35 | 
    Takuya Naruto 
      [Kumamoto Univ.] | 
    Selection of HLA-B57-associated Gag A146P mutant by HLA-B*4801-resticted CTLs in HLA-B57-negative Japanese cohort | 
  
   
    
  | 
  
      
    | P-36 | 
    Kazutaka Honda 
      [Kumamoto Univ.] | 
    Selection of HIV-1 escape mutant by HLA-Cw*1202-restricted 
      Pol-specific cytotoxic T lymphocytes having a strong ability to suppress HIV-1 replication | 
  
   
    
  | 
  
      
    | P-37 | 
    Tomohiro Akahoshi 
      [Kumamoto Univ.] | 
    HIV-1-specific cytotoxic T lymphocytes having cross-recognition for
escape mutation | 
  
   
    
  | 
  
      
    | P-38 | 
    Tamayo Watanabe 
      [Univ. of Toyama / Kumamoto
Univ.] | 
    Identification and characterization of 5 novel HIV-1 Integrase-specific
HLA-B*4002-restricted CTL epitopes | 
  
   
    
  | 
  
      
    | P-39 | 
    Madoka Koyanagi 
      [Kumamoto Univ.] | 
    HIV-1-specific CD4+ T cell response to HIV-1 Nef, Gag and Pol in
Japanese cohort | 
  
   
    
  | 
  
      
    | P-40 | 
    Hayato Murakoshi 
      [Kumamoto Univ.] | 
    Comprehensive analysis of HIV-1-specific CD8+ T cell responses in
chronically HIV-1-infected Japanese cohort | 
  
   
    
  | 
  
      
    | P-41 | 
    Takayuki Chikata 
      [Kumamoto Univ.] | 
    HLA-Associated Viral Polymorphism in Chronically HIV-1 Infected
Japanese Cohort | 
  
   
    
  | 
  
      
    | P-42 | 
    Jagdagsuren Davaalkham 
      [NCGM] | 
    Emergence of HIV-1 Subtype B outbreak in Mongolia | 
  
   
    
  | 
  
      
    | P-43 | 
    Koji Watanabe 
      [NCGM / Kumamoto Univ.] | 
    Clinical features of amoebic diseases in HIV-infected individuals in Japan | 
  
   
    
  | 
  
      
    | P-44 | 
    Tsunefusa Hayashida 
      [NCGM / Kumamoto Univ.] | 
    Trends in early identification of HIV infection in Tokyo analyzed by BED
assay | 
  
   
    
  | 
  
      
    | P-45 | 
    Takeshi Nishijima 
      [NCGM] | 
    The impact of weight on Tenofovir-induced renal dysfunction among
Japanese patients with HIV-1 infection | 
  
   
    
  | 
  
      
    | P-46 | 
    Takayoshi Koyama 
      [NCGM] | 
    Integration into DNA double-strand break sites of HIV-1 is not attenuated by raltegravir, an integrase inhibitor | 
  
   
    
  | 
  
      
    | P-47 | 
    Kazuhiko Ide 
      [Kumamoto Univ.] | 
    Novel HIV-1 protease inhibitors (PIs) containing bis-tetrahydrofuran (bis-THF) and a novel polycyclic ligand | 
  
   
    
  | 
  
      
    | P-48 | 
    Manabu Aoki 
      [Kumamoto Health Science
Univ.] | 
    Tipranavir-resistant HIV-1 loses both protease enzymatic inhibition and dimerization inhibition activity | 
  
   
    
  | 
  
      
    | P-49 | 
    Masayuki Amano 
      [Kumamoto Univ.] | 
    Inserts in Gag Proteins Elicit Degradation of the Gag Proteins in Multi-drug-resistant HIV Variants | 
  
   
    
  | 
  
      
    | P-50 | 
    Matthew L. Danish 
     [Kumamoto Univ.] | 
    Emergence of HIV-1 Variants Highly Resistant to Darunavir and the Resistance Mechanism | 
  
   
    
  | 
  
      
    | P-51 | 
    P. Miguel Salcedo-Gomez 
      [Kumamoto Univ.] | 
    An unreported insert QQATADT in the Gag-encoding region of HIV-1 isolated from a treatment-experienced HIV-1-infected patients |